
Voglichew 0.3 Tablet MD
Marketer
Emphaatic Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglichew 0.3 Tablet MD
Diabetol 0.3mg tablets are indicated for managing type 2 diabetes. This medication aids in postprandial blood glucose regulation, employed when dietary modifications and other comparable therapies prove insufficient. Diabetol 0.3mg tablets should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize glycemic control. Abrupt cessation should be avoided; discontinuation without medical supervision risks hyperglycemia and associated complications, potentially including renal impairment and vision loss. This medication forms part of a comprehensive treatment strategy, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Common adverse effects may encompass flatulence, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While Diabetol 0.3mg tablets do not intrinsically induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) elevates this risk. Hypoglycemic episodes necessitate treatment with pure glucose; sucrose is ineffective in this context. Prior to commencing therapy, inform your physician of any hepatic or renal dysfunction. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Consult your physician before use during pregnancy or lactation. Disclose all concurrent medications to ensure medication safety. Limit alcohol consumption to mitigate the risk of hypoglycemia.
Uses of Voglichew 0.3 Tablet MD
Managing type 2 diabetes
Major Benefits of Voglichew 0.3 Tablet MD:
Administer Voglichew 0.3 Tablet MD as prescribed by your physician, adhering strictly to the recommended dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, allowing it to dissolve before swallowing. This medication should be taken on an empty stomach.
Common Side effects of Voglichew 0.3 Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglichew 0.3 Tablet MD:
Administer Voglichew 0.3 Tablet MD as prescribed by your physician, adhering to the specified dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. This medication should be taken on an empty stomach.
How Voglichew 0.3 Tablet MD works:
Voglichew 0.3 MD tablets are used to manage diabetes. Their mechanism involves blocking enzymes in the intestines that digest complex carbohydrates, thus mitigating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglichew 0.3 Tablet MD and alcohol is not recommended due to safety concerns.
PregnancySAFE IF PRESCRIBED
Use of Voglichew 0.3 mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglichew 0.3 Tablet MD safely. Preliminary human studies indicate minimal infant risk from this medication.
DrivingSAFE
Driving ability is typically unaffected by Voglichew 0.3 mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglichew 0.3 Tablet MD cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglichew 0.3 Tablet MD cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglichew 0.3 Tablet MD :
Omit any missed dose of Voglichew 0.3mg Tablet MD and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglichew 0.3 Tablet MD
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
